THE 2-MINUTE RULE FOR ABBV-744 AND OTHER BRD4 INHIBITORS COMPARISON

In Phase A, members will receive various doses and schedules of oral ABBV-744 pill to determine Secure dosing program. More members will likely be enrolled on the identified monotherapy dosign routine. In Segment B, members will obtain oral ruxolitinib and ABBV-744 will probably be given as "insert-on" therapy. In Segment C, contributors will obtai